Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.

Muruato, Antonio E; Fontes-Garfias, Camila R; Ren, Ping; Garcia-Blanco, Mariano A; Menachery, Vineet D; Xie, Xuping; Shi, Pei-Yong

Muruato, Antonio E; Fontes-Garfias, Camila R; Ren, Ping; Garcia-Blanco, Mariano A; Menachery, Vineet D; Xie, Xuping; Shi, Pei-Yong.

Muruato AE; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Fontes-Garfias CR; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Ren P; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Garcia-Blanco MA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Menachery VD; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Xie X; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
Shi PY; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.

Nat Commun ; 12(1): 4000, 2021 Jun 22.

Article in English | MEDLINE | ID: covidwho-1307324

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Topics: Vaccines Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S41467-021-24287-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google